What is the first-line treatment for infective endocarditis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The first-line treatment for infective endocarditis is antibiotic therapy, which should be started promptly after drawing three sets of blood cultures at 30-min intervals 1.

Empirical Treatment Regimens

The initial choice of empirical treatment depends on several considerations, including whether the patient has received previous antibiotic therapy, whether the infection affects a native valve or a prosthesis, and the place of the infection (community, nosocomial, or non-nosocomial healthcare-associated IE) 1.

  • For community-acquired native valves or late prosthetic valves (≥12 months post surgery) endocarditis, proposed antibiotic regimens include:
    • Ampicillin 12 g/day i.v. in 4–6 doses
    • (Flu)cloxacillin or oxacillin 12 g/day i.v. in 4–6 doses
    • Gentamicin 3 mg/kg/day i.v. or i.m. in 1 dose
    • Vancomycin 30–60 mg/kg/day i.v. in 2–3 doses for penicillin-allergic patients 1
  • For early PVE (<12 months post surgery) or nosocomial and non-nosocomial healthcare associated endocarditis, proposed antibiotic regimens include:
    • Vancomycin 30 mg/kg/day i.v. in 2 doses
    • Gentamicin 3 mg/kg/day i.v. or i.m. in 1 dose
    • Rifampin 900–1200 mg i.v. or orally in 2 or 3 divided doses 1

Duration of Treatment

The duration of treatment for infective endocarditis is typically 4-6 weeks, but may vary depending on the specific pathogen and the patient's response to treatment 1.

Consultation with an Infectious Diseases Specialist

Consultation with an infectious diseases specialist is recommended to define the most appropriate choice of therapy, especially in cases of culture-negative endocarditis or when the patient has received previous antibiotic therapy 1.

Monitoring and Adjustment of Treatment

Monitoring of gentamicin or vancomycin dosages is crucial to avoid toxicity, and treatment should be adjusted based on the patient's response and the results of blood cultures 1.

From the Research

First-Line Treatment for Infective Endocarditis

The first-line treatment for infective endocarditis involves a combination of anti-microbial therapy and close monitoring by a multidisciplinary team of specialists, including cardiologists, microbiologists, and cardiac surgeons 2, 3, 4.

Anti-Microbial Therapy

  • Intravenous antibiotics are the primary treatment for infective endocarditis, with the specific antibiotic regimen adapted to the responsible germ 3, 4.
  • The duration of antibiotic therapy is typically prolonged, with a minimum of two weeks of parenteral antibiotic therapy initiated in the hospital 4.
  • Outpatient antibiotic treatment may be considered depending on the patient's evolution, and oral antibiotics may be proposed in stable patients when the infection is caused by common germs 4.

Surgical Intervention

  • Surgical treatment is reserved for certain complications of infective endocarditis, such as heart failure, uncontrolled infection, and prevention of embolic risk 3, 4.
  • The surgical treatment aims to excise the infected tissues and restore valvular function, with conservative surgical treatment performed when possible, and valve replacement as an alternative 4.
  • The recognition of surgical indications is essential to improve the prognosis of patients with infective endocarditis 4.

Multidisciplinary Care

  • A multidisciplinary care team, including infectious disease, cardiology, and cardiac surgery physicians, is recommended to reduce complications and improve patient outcomes 3, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Infective Endocarditis.

Journal of intensive care medicine, 2016

Research

[Treatment of infective endocarditis].

La Revue du praticien, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.